The potential role of fucosylated cationic liposome/NFκB decoy complexes in the treatment of cytokine-related liver disease

Biomaterials

Volumn 28, Issue 3, 2007, Pages 532-539

  Higuchi, Yuriko ^a   Kawakami, Shigeru ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Fucosylated cationic liposome; Gene delivery; Gene therapy; Kupffer cell; NF B decoy; Targeting

Indexed keywords

FUCOSYLATED CATIONIC LIPOSOME; GENE DELIVERY; GENE THERAPY; KUPFFER CELL; NFΚB DECOY; TARGETING;

CELLS; DISEASES; GENETIC ENGINEERING; TISSUE;

BIOTECHNOLOGY;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEN 5 YLOXY N [4 [(1 IMINO 2 THIOFUCOSYLETHYL)AMINO]BUTYL]FORMAMIDE; CYTOKINE; FORMAMIDE DERIVATIVE; GADOLINIUM CHLORIDE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOSOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FEMALE; FUCOSYLATION; KUPFFER CELL; LIVER DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATIONS; CYTOKINES; ENDOTOXINS; FEMALE; FUCOSE; GENE THERAPY; GENE TRANSFER TECHNIQUES; KUPFFER CELLS; LIPOSOMES; LIVER DISEASES; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; NF-KAPPA B;

EID: 33750164657     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.08.045     Document Type: Article

References (34)

1. Morrison D.C., and Ryan J.L. Endotoxins and disease mechanisms. Annu Rev Med 38 (1987) 417-432
2. Ponnappa B.C., Dey I., Tu G.C., Zhou F., Aini M., Cao Q.N., et al. In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor in rats. J Pharmacol Exp Ther 297 (2001) 1129-1136
3. Pahl H.L. Activations and target genes of Rel/NF-κB transcription factors. Oncogene 18 (1999) 6853-6866
4. Handa O., Naito Y., Takagi T., Shimozawa M., Kokura S., Yoshida N., et al. Tumor necrosis factor-alpha-induced cytokine-induced neutrophil chemoattractant-1 (CINC-1) production by rat gastric epithelial cells: role of reactive oxygen species and nuclear factor-κB. J Pharmacol Exp Ther 309 (2004) 670-676
5. Wrighton C.J., Hofer-Warbinek R., Moll T., Eytner R., Bach F.H., and de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBa, an inhibitor of the transcription factor NF-κB. J Exp Med 183 (1996) 1013-1022
6. Foxwell B., Browne K., Bondeson J., Clarke C., de Martin R., Brennan F., et al. Efficient adenoviral infection with IκBa reveals that macrophage TNFα production in rheumatoid arthritis is NF-κB dependent. Proc Natl Acad Sci USA 95 (1998) 8211-8215
7. Bielinska A., Shivdasani R.A., Zhang L.Q., and Nabel G.J. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250 (1990) 997-1000
8. Morishita R., Higaki J., Tomita N., and Ogihara T. Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res 82 (1998) 1023-1028
9. Morishita R., Sugimoto T., Aoki M., Kida I., Tomita N., Moriguchi A., et al. In vivo transduction of cis element decoy against nuclear factor-κB binding siteprevents myocardial infraction. Nat Med 3 (1997) 894-899
10. Griesenbach U., Scheid P., Hillery E., de Martin R., Huang L., Geddes D.M., et al. Anti-inflammatory gene therapy directed at the airway epithelium. Gene Ther 7 (2000) 306-313
11. Higuchi Y., Kawakami S., Nishikawa M., Yamashita F., and Hashida M. Intracellular distribution of NFκB decoy and its inhibitory effect on TNFα production by LPS stimulated RAW 264.7 cells. J Control Release 107 (2005) 373-382
12. Kawakami S., Yamashita F., Nishida K., Nakamura J., and Hashida M. Glycosylated cationic liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst 19 (2002) 171-190
13. Kawakami S., Sato A., Nishikawa M., Yamashita F., and Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 7 (2000) 292-299
14. Yamada M., Nishikawa M., Kawakami S., Hattori Y., Nakano T., Yamashita F., et al. Tissue and intrahepatic distribution and subcellular localization of a mannosylated lipoplex after intravenous administration in mice. J Control Release 98 (2004) 157-167
15. Hattori Y., Kawakami S., Suzuki S., Yamashita F., and Hashida M. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem Biophys Res Commun 317 (2004) 992-999
16. Opanasopit P., Nishikawa M., Yamashita F., Takakura Y., and Hashida M. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells. J Drug Target 9 (2001) 341-351
17. Kuiper J., Brouwer A., Knook D.L., and van Berkel T.J.C. Kupffer and sinusoidal endothelial cells. In: Arias I.M., Boyer J.L., Fausto N., Jakoby W.B., Schachter D.A., and Shafritz D.A. (Eds). The liver: biology and pathobiology. 3rd ed (2001), Raven Press, New York 791-818
18. Kawakami S., Wong J., Sato A., Hattori Y., Yamashita F., and Hashida M. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta 1524 (2000) 258-265
19. Hattori Y., Suzuki S., Kawakami S., Yamashita F., and Hashida M. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J Control Release 108 (2005) 484-495
20. Yeeprae W., Kawakami S., Higuchi Y., Yamashita F., and Hashida M. Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice. J Drug Target 13 (2005) 479-487
21. Yang J.P., and Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther 4 (1997) 950-960
22. Higuchi Y., Kawakami S., Oka M., Yamashita F., and Hashida M. Suppression of TNFα production in LPS induced liver failure mice after intravenous injection of cationic liposome/NFκB decoy complex. Pharmazie 61 (2006) 144-147
23. Hardonk M.J., Dijkhuis F.W., Hulstaert C.E., and Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 52 (1992) 296-302
24. Rüttinger D., Vollmar B., Wanner G.A., and Messmer K. In vivo assessment of hepatic alterations following gadolinium chloride-induced Kupffer cell blockade. J Hepatol 25 (1996) 960-967
25. Mas A., and Rodés J. Fulminant hepatic failure. Lancet 349 (1997) 1081-1085
26. Roland N., Wade J., Davalos M., Wendon J., Philpott-Howars J., and Williams R. The system inflammatory response syndrome in acute liver failure. Hepatology 32 (2000) 734-739
27. 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol 45 (1994) 932-943
28. Brenner B.M., Hostetter T.H., and Humes H.D. Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Am J Physiol 234 (1978) F455-F460
29. Dzau V.J., Mann M.J., Morishita R., and Kaneda Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc Natl Acad Sci USA 93 (1996) 11421-11425
30. κB decoy complexes effectively prevent LPS-induced cytokine production in a murine liver model. FEBS Lett 580 (2006) 3706-3714
31. Ogawara K., Hasegawa S., Nishikawa M., and Hashida M. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatoropic ligands. J Drug Target 6 (1999) 349-360
32. Yoshida M., Yamamoto N., Uehara T., Terao R., Nitta R., Harada N., et al. Kupffer cell targeting by intraportal injection of the HVJ cationic liposome. Eur Surg Res 34 (2002) 251-259
33. Ogushi I., Iimuro Y., Seki E., Son G., Hirano T., Hada T., et al. Nuclear factor κB decoy oligonucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology 38 (2003) 335-344
34. Hirano T., Fujimoto J., Ueki T., Yamamoto H., Iwasaki T., Morisita R., et al. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. Gene Ther 5 (1998) 459-464